Comosystems Compensating Magnetic Oscillator (CMO) products are the culmination of many years work and research into the biological effects of EMFs by top research scientists from around the world.
Over 25 years of Research
Comosystems core team was put together in the 1990s by the founder, Mr Maurice Fillion-Robin. His scientific background at the mid Pharmaceutical Laboratories ensured the exacting methodology and research behind the development of the original CMO devices.
They have since been further developed to keep up with the change in frequencies used by Telecoms.
Over 10 years of Independent Tests
Having developed CMO technology to mitigate for the adverse effects, independent research was conducted in various universities around the world to validate the new biomagnetic technology.
All research was published in either peer-reviewed Journals or presented at relevant Conferences. Papers in theoretical physics are available for specialists on the Internet and direct access to the authors cited.
The human studies were double-blinded. This means that participants were given either an active compensating magnetic oscillator, or an identical placebo. The results were analyzed statistically.
It is important to note that these study results are completely independent of the industries that produce electromagnetic fields.
Research. Study. Independent Reports.
Mr Fillion-Robin considered it a basic requirement before going to market to establish that CMO has irrefutable biological evidence.
The approach has been to follow the sequence of events employed by Pharmaceutical Laboratories when they launch a new drug.
Initial studies, then trials, placebos, witnesses, interpretation of results, participation of high-level researchers, publications in Congress and in Scientific Journals.
Thank You for visiting Comosystems, looking and learning about who we are and Our Products to protect against EMR that is constantly all around us.
Any questions just let us know.
Health and Happiness